133 related articles for article (PubMed ID: 32194750)
1. C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10.
Nozaki E; Kobayashi T; Ohnishi H; Ohtsuka K; Masaki T; Watanabe T; Sugiyama M
Oncol Lett; 2020 Mar; 19(3):2495-2501. PubMed ID: 32194750
[TBL] [Abstract][Full Text] [Related]
2. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.
Li H; Rong S; Chen C; Fan Y; Chen T; Wang Y; Chen D; Yang C; Yang J
Mol Carcinog; 2019 Feb; 58(2):171-184. PubMed ID: 30302818
[TBL] [Abstract][Full Text] [Related]
3. CXCR3A contributes to the invasion and metastasis of gastric cancer cells.
Yang C; Zheng W; Du W
Oncol Rep; 2016 Sep; 36(3):1686-92. PubMed ID: 27461521
[TBL] [Abstract][Full Text] [Related]
4. Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?
Urra S; Fischer MC; Martínez JR; Véliz L; Orellana P; Solar A; Bohmwald K; Kalergis A; Riedel C; Corvalán AH; Roa JC; Fuentealba R; Cáceres CJ; López-Lastra M; León A; Droppelmann N; González HE
Oncotarget; 2018 Jan; 9(2):2445-2467. PubMed ID: 29416784
[TBL] [Abstract][Full Text] [Related]
5. Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.
Shen D; Cao X
Int J Clin Exp Pathol; 2015; 8(7):8091-8. PubMed ID: 26339376
[TBL] [Abstract][Full Text] [Related]
6. C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.
Smith JS; Alagesan P; Desai NK; Pack TF; Wu JH; Inoue A; Freedman NJ; Rajagopal S
Mol Pharmacol; 2017 Aug; 92(2):136-150. PubMed ID: 28559424
[TBL] [Abstract][Full Text] [Related]
7. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
Wu Q; Dhir R; Wells A
Mol Cancer; 2012 Jan; 11():3. PubMed ID: 22236567
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays.
Nguyen HT; Hurh S; Nguyen LP; Nguyen TU; Park HK; Seong JY; Lee CS; Ham BJ; Hwang JI
Mol Cells; 2023 May; 46(5):281-297. PubMed ID: 36799104
[TBL] [Abstract][Full Text] [Related]
9. The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells.
Kundu N; Ma X; Brox R; Fan X; Kochel T; Reader J; Tschammer N; Fulton A
Breast Cancer (Auckl); 2019; 13():1178223419873628. PubMed ID: 31619923
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH
J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229
[TBL] [Abstract][Full Text] [Related]
11. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
Chakraborty K; Bose A; Pal S; Sarkar K; Goswami S; Ghosh D; Laskar S; Chattopadhyay U; Baral R
Int Immunopharmacol; 2008 Feb; 8(2):330-40. PubMed ID: 18182249
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
[TBL] [Abstract][Full Text] [Related]
13. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
Berchiche YA; Sakmar TP
Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
[TBL] [Abstract][Full Text] [Related]
14. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
15. Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.
Furuya M; Yoneyama T; Miyagi E; Tanaka R; Nagahama K; Miyagi Y; Nagashima Y; Hirahara F; Inayama Y; Aoki I
Gynecol Oncol; 2011 Sep; 122(3):648-55. PubMed ID: 21684584
[TBL] [Abstract][Full Text] [Related]
16. CXCR3 expression in colorectal cancer cells enhanced invasion through preventing CXCR4 internalization.
Jin J; Zhang Z; Wang H; Zhan Y; Li G; Yang H; Fei Z; Xu Y; Li W
Exp Cell Res; 2018 Oct; 371(1):162-174. PubMed ID: 30092218
[TBL] [Abstract][Full Text] [Related]
17. The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer.
Kuo PT; Zeng Z; Salim N; Mattarollo S; Wells JW; Leggatt GR
Front Med (Lausanne); 2018; 5():271. PubMed ID: 30320116
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 ligands in disease and therapy.
Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
[TBL] [Abstract][Full Text] [Related]
19. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of pericyte function by the CXC receptor 3.
Bodnar RJ; Wells A
Wound Repair Regen; 2015; 23(6):785-96. PubMed ID: 26207932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
